Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
International Anesthesiology Clinics|January 1, 1995
The development of hemoglobin solutions as red cell substitutesJ E Ogden, E S ParryTrends in Biotechnology|March 1, 1992
Recombinant haemoglobin in the development of red-blood-cell substitutesJ E OgdenTrends in Biotechnology|February 1, 1995
Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent?J E Ogden, P K MooreCurrent Genetics|January 1, 1986
Isolation of a novel type of mutation in the mitotic control of Schizosaccharomyces pombe whose phenotypic expression is dependent on the genetic background and nutritional environmentJ E Ogden, P A FantesVox Sanguinis|January 1, 1995
Haemoglobin-based red cell substitutes: current statusJ E Ogden, S L Mac DonaldVox Sanguinis|January 1, 1979
Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectantJ M Mishler, E S ParryEuropean Journal of Clinical Investigation|April 1, 1984
Effects on renal tubular protein reabsorption of the infusion of free haemoglobinJ T Whicher, E S ParryJournal of Biotechnology|February 21, 1995
High level synthesis and secretion of human urokinase using a late gene promoter of the Autographa californica nuclear polyhedrosis virusA M Lawrie, L A King, J E OgdenBritish Journal of Haematology|October 1, 1978
Plasma clearance and renal excretion of erythrocyte cryoprotectant hydroxyethylated amylopectinJ M Mishler, E S Parry, A PetriePageof 3